Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

被引：0
|
作者：
Williams, Loretta A.
Ault, Patricia S.
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
Quintas-Cardama, Alfonso
Borthakur, Gautam
Faderl, Stefan H.
Jabbour, Elias J.
Cleeland, Charles S.
Cortes, Jorge E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2988
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    ANDREEFF, M
    STONE, R
    YOUNG, C
    TONG, W
    ERVIN, T
    TAFURI, A
    KOLITZ, J
    RIFKIND, R
    KUFE, D
    MARKS, P
    LEUKEMIA, 1991, 5 (02) : 174 - 174
  • [32] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
    Padmanabhan, A.
    Block, A.
    Sait, S.
    Ford, L. A.
    O'Connor, T. L.
    Moysich, K. B.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] TRISOMY-14 IN ACUTE MYELOGENOUS LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS)
    TOZE, CL
    BARNETT, MJ
    NAIMAN, SC
    HORSMAN, DE
    BLOOD, 1994, 84 (10) : A626 - A626
  • [34] Integrated functional proteomic profiling in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): MDS-like signature is associated with favorable outcome in patients with AML
    Chae, Young Kwang
    Yoo, Suk Young
    Coombes, Kevin R.
    Kornblau, Steven M.
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Cortes, Jorge E.
    Faderl, Stefan
    Pagel, John
    Jung, Chul Won
    Yoon, Sung-Soo
    Koh, Youngil
    Pardanani, Animesh Dev
    Hauptschein, Robert S.
    Lee, Kyoung-June
    Lee, Je-Hwan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Prognostic factors for allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Wong, R
    Shahjahan, M
    De Lima, M
    Anagnostopoulos, A
    Estey, E
    Champlin, R
    Andersson, B
    Khouri, I
    Giralt, S
    BLOOD, 2002, 100 (11) : 853A - 853A
  • [37] LOW-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS)
    WEH, HJ
    ZSCHABER, R
    HOSSFELD, DK
    BLUT, 1984, 48 (04): : 239 - 242
  • [38] Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
    Amanda F. Cashen
    Ajit K. Shah
    Laura Todt
    Nicholas Fisher
    John DiPersio
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 759 - 766
  • [39] CONCOMITANT MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE (MGUS) IN NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA (MDS/AML)
    Chen, Mingyi
    La, Hanh
    Abedi, Mehrdad
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 47 - 48
  • [40] Treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic cell transplantation (HCT).
    Chiattone, A.
    Andersson, B.
    Bashir, Q.
    Landau, D.
    Rondon, G.
    Nieto, Y.
    Al Atrash, G.
    Giralt, S.
    Champlin, R. E.
    De Lima, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345